taxonomy (14)
protein (77)
source (16)
structure (23)
composition (1)
disease (3)
reference (27)
site (118)
peptide (160)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Capra hircus (Goat)
- Mus musculus (House mouse)
- Nasua narica (White-nosed coati)
- Pongo pygmaeus (Orangutan)
- Rattus norvegicus (Norway rat)
- Ursus americanus (Black bear)
- Todarodes pacificus (Japanese flying squid)
- Trichinella spiralis
- Megathura crenulata (Californian giant keyhole limpet)
- Apis mellifera (Honeybee)
- Drosophila melanogaster (Fruit fly)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Acid ceramidase / Homo sapiens Q13510
- Adipocyte plasma membrane-associated protein / Homo sapiens Q9HDC9
- Alpha-fetoprotein / Homo sapiens P02771
- Alpha-galactosidase A / Homo sapiens P06280
- Alpha-n-acetylgalactosaminidase / Homo sapiens P17050
- Apolipoprotein d / Homo sapiens P05090
- Arylsulfatase a / Homo sapiens P15289
- C-type mannose receptor 2 / Homo sapiens Q9UBG0
- Cap-gly domain-containinglinker protein 1 / Homo sapiens P30622
- Cathepsin D / Homo sapiens P07339
- Cation-independent mannose-6-phosphate receptor / Homo sapiens P11717
- Ceramide synthase 2 / Homo sapiens Q96G23
- Ceramide synthase 6 / Homo sapiens Q6ZMG9
- Clusterin / Homo sapiens P10909
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Dipeptidyl peptidase 1 / Homo sapiens P53634
- Endoplasmin / Homo sapiens P14625
- Fibrillin-1 / Homo sapiens P35555
- Fibrillin-2 / Homo sapiens P35556
- Fibrillin-3 / Homo sapiens Q75N90
- Gamma-glutamyl hydrolase / Homo sapiens Q92820
- Gamma-interferon-inducible lysosomal thiol reductase / Homo sapiens P13284
- Hypoxia up-regulated protein 1 / Homo sapiens Q9Y4L1
- Immunoglobulin heavy constant gamma 2 / Homo sapiens P01859
- Integrin beta-1 / Homo sapiens P05556
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens Q14767
- Low-density lipoprotein receptor / Homo sapiens P01130
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Multimerin-1 / Homo sapiens Q13201
- N-acetylglucosamine-6-sulfatase / Homo sapiens P15586
- Neurocan core protein / Homo sapiens O14594
- Palmitoyl-protein thioesterase 1 / Homo sapiens P50897
- Prenylcysteine oxidase 1 / Homo sapiens Q9UHG3
- Prosaposin / Homo sapiens P07602
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens Q9BYF1
- Serpin h1 / Homo sapiens P50454
- Sortilin-related receptor / Homo sapiens Q92673
- Sulfhydryl oxidase 1 / Homo sapiens O00391
- Tenascin / Homo sapiens P24821
- Thyroglobulin / Homo sapiens P01266
- Transmembrane protein 106B / Homo sapiens Q9NUM4
- Transmembrane protein 245 / Homo sapiens Q9H330
- Tryptase alpha/beta-1 / Homo sapiens Q15661
- Tryptase beta-2 / Homo sapiens P20231
- Tyrosine-protein phosphatase non-receptor type substrate 1 / Homo sapiens P78324
- Thyrotropin-aplha and beta chains / Bos taurus P01217 P01223
- Mucin / Capra hircus
- Cathepsin D / Mus musculus P18242
- G-protein coupled receptor 56 / Mus musculus Q8K209
- Hypoxia up-regulated protein 1 / Mus musculus Q9JKR6
- Immunoglobulin superfamily member 8 / Mus musculus Q8R366
- Isoform 3 of Inositol 1,4,5-trisphosphate receptor type 1 / Mus musculus P11881-3
- Leukocyte surface antigen CD47 / Mus musculus Q61735
- Lysosomal acid phosphatase / Mus musculus P24638
- Lysosomal alpha-glucosidase / Mus musculus P70699
- Lysosome-associated membrane glycoprotein 2 / Mus musculus P17047
- Metabotropic glutamate receptor 3 / Mus musculus Q9QYS2
- Myelin-associated glycoprotein / Mus musculus P20917
- Neural cell adhesion molecule L1 / Mus musculus P11627
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus Q91ZX7
- Prosaposin / Mus musculus Q61207
- Reticulocalbin-1 / Mus musculus Q05186
- Signal-regulatory protein alpha / Mus musculus P97797
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Wolframin / Mus musculus P56695
- Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus P08289
- Rhodopsin / Todarodes pacificus P31356
- Tsl-1 antigens / Trichinella spiralis
- Uncharacterized protein from Whole Organism / Trichinella spiralis
- Hemocyanin / Megathura crenulata Q10583 Q10584
- Phospholipase a2 / Apis mellifera P00630
- Uncharacterized protein from Undefined tissue / Drosophila melanogaster
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Hemolymph (UBERON_0001011)
- Kidney (UBERON_0002113) HEK293T (CVCL_0063)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Pituitary Gland (UBERON_0000007)
- Placenta (UBERON_0001987)
- Retina (UBERON_0000966) Plasma Membrane (GO_0005886)
- Submandibular Gland (UBERON_0001736)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Venom (UBERON_0007113)
- BTI-Tn-5B1-4 (CVCL_C190)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
Source
- Free / Lactose / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-6)[Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc
- Free / Lactose / Structure 8968
- Free / Lactose / [[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-6)][Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [[Fuc(a1-3)]Gal(b1-4)GlcNAc(b1-6)][Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Fuc(a1-2)]Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-6)][Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-2)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-?)]Gal(b1-4)Glc
- Free / Lactose / Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)Glc(b1-
- Free / Lactose / Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)Glc(b1-
- N-Linked / High-Mannose / Man(?1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-3)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-6)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-?)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Structure 834
- N-Linked / Pauci-Mannose / Gal(b1-6)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Gal(b1-4)Fuc(a1-6)]GlcNAc
- O-Linked / Undefined core / Man(?1-4)[Man(?1-6)]Glc(?1-4)GlcNAc(?1-4)[Fuc(?1-2)]Gal(?1-3)GalNAc
Reported structure
- Hex:4 HexNAc:2 dHex:1 (avg mass : 1219.1179 )
Composition
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Systematic Review of the Concentrations of Oligosaccharides in Human Milk (2017 - Stephan Thurl, Manfred Munzert, Günther Boehm, Catherine Matthews, Bernd Stahl) / Status : Unreviewed
- Synthesis of Asymmetrical Multiantennary Human Milk Oligosaccharides (2017 - Anthony R Prudden, Lin Liu, Chantelle J Capicciotti, Margreet A Wolfert, Shuo Wang, Zhongwei Gao, Lu Meng, Kelley W Moremen, Geert-Jan Boons) / Status : Unreviewed
- Human Milk Oligosaccharides (HMOS): Structure, Function, and Enzyme-Catalyzed Synthesis (2015 - Xi Chen) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Site-specific characterization of cell membrane N-glycosylation with integrated hydrophilic interaction chromatography solid phase extraction and LC-MS/MS (2014 - Chen R, Seebun D, Ye M, Zou H, Figeys D) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
- N-glycan structures of squid rhodopsin. Existence of the alpha1-3 and alpha1-6 difucosylated innermost GlcNAc residue in a molluscan glycoprotein. (2003 - Takahashi N, Masuda K, Hiraki K, Yoshihara K, Huang HH, Khoo KH, Kato K) / Status : Reviewed
- Hemocyanin from the keyhole limpet Megathura crenulata (KLH) carries a novel type of N-glycans with Gal(beta1-6)Man-motifs. (2002 - Kurokawa T, Wuhrer M, Lochnit G, Geyer H, Markl J, Geyer R) / Status : Reviewed
- Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation (2001 - Chaturvedi, Warren, Altaye, Morrow, Ruiz-Palacios, Pickering, Newburg) / Status : Reviewed
- Comparison of oligosaccharides in milk specimens from humans and twelve other species. (2001 - Warren CD, Chaturvedi P, Newburg AR, Oftedal OT, Tilden CD, Newburg DS) / Status : Reviewed
- Extension of the in-gel release method for structural analysis of neutral and sialylated N-linked glycans to the analysis of sulfated glycans: application to the glycans from bovine thyroid-stimulating hormone (2001 - Wheeler, Harvey) / Status : Reviewed
- Identification of core alpha 1,3-fucosylated glycans and cloning of the requisite fucosyltransferase cDNA from Drosophila melanogaster. Potential basis of the neural anti-horseradish peroxidase epitope. (2001 - Fabini G, Freilinger A, Altmann F, Wilson I) / Status : Reviewed
- Phosphorylcholine-containing N-glycans of Trichinella spiralis: identification of multiantennary lacdiNAc structures. (2000 - Morelle W, Haslam S, Olivier V, Appleton J, Morris H, Dell A) / Status : Reviewed
- High-mannose-type oligosaccharides from human placental arylsulfatase A are core fucosylated as confirmed by MALDI MS. (2000 - Hoja-Lukowicz D, Cioczyk D, Bergquist J, Lityska A, Laidler P) / Status : Reviewed
- Characterization of the N-linked glycans of adult Trichinella spiralis. (2000 - Morelle W, Haslam S, Morris H, Dell A) / Status : Reviewed
- Chemical characterisation of the oligosaccharides in a sample of milk of a white-nosed coati, Nasua narica (Procyonidae: Carnivora). (1999 - Urashima T, Yamamoto M, Nakamura T, Arai I, Saito T, Namiki M, Yamaoka K, Kawahara K) / Status : Reviewed
- Comparative study of the sugar chains of alkaline phosphatases purified from rat liver and rat AH-130 hepatoma cells. Occurrence of fucosylated high-mannose-type and hybrid-type sugar chains. (1996 - Endo T, Fujiwara T, Ikehara Y, Kobata A) / Status : Reviewed
- Characterization of the oligosaccharide structures on bee venom phospholipase A2. (1993 - Hollander T, Aeed P, Elhammer A) / Status : Reviewed
- Structures of carbohydrate chains of glycoprotein isolated from goat submaxillary mucin. (1982 - Dutta B, Rao C) / Status : Reviewed
Reference
- Acid ceramidase / Homo sapiens
- Adipocyte plasma membrane-associated protein / Homo sapiens
- Alpha-fetoprotein / Homo sapiens
- Alpha-galactosidase A / Homo sapiens
- Alpha-n-acetylgalactosaminidase / Homo sapiens
- Apolipoprotein d / Homo sapiens
-
Arylsulfatase a / Homo sapiens
- Undefined site
- C-type mannose receptor 2 / Homo sapiens
- Cap-gly domain-containinglinker protein 1 / Homo sapiens
- Cathepsin D / Homo sapiens
- Cation-independent mannose-6-phosphate receptor / Homo sapiens
- Ceramide synthase 2 / Homo sapiens
- Ceramide synthase 6 / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Dipeptidyl peptidase 1 / Homo sapiens
- Endoplasmin / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrillin-2 / Homo sapiens
- Fibrillin-3 / Homo sapiens
- Gamma-glutamyl hydrolase / Homo sapiens
- Gamma-interferon-inducible lysosomal thiol reductase / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens
- Low-density lipoprotein receptor / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Multimerin-1 / Homo sapiens
- N-acetylglucosamine-6-sulfatase / Homo sapiens
- Neurocan core protein / Homo sapiens
- Palmitoyl-protein thioesterase 1 / Homo sapiens
- Prenylcysteine oxidase 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Serpin h1 / Homo sapiens
- Sortilin-related receptor / Homo sapiens
- Sulfhydryl oxidase 1 / Homo sapiens
- Tenascin / Homo sapiens
- Thyroglobulin / Homo sapiens
- Transmembrane protein 106B / Homo sapiens
- Transmembrane protein 245 / Homo sapiens
- Tryptase alpha/beta-1 / Homo sapiens
- Tryptase beta-2 / Homo sapiens
- Tyrosine-protein phosphatase non-receptor type substrate 1 / Homo sapiens
-
Thyrotropin-aplha and beta chains / Bos taurus
- Undefined site
-
Mucin / Capra hircus
- Undefined site
- Cathepsin D / Mus musculus
- G-protein coupled receptor 56 / Mus musculus
- Hypoxia up-regulated protein 1 / Mus musculus
- Immunoglobulin superfamily member 8 / Mus musculus
- Isoform 3 of Inositol 1,4,5-trisphosphate receptor type 1 / Mus musculus
- Leukocyte surface antigen CD47 / Mus musculus
- Lysosomal acid phosphatase / Mus musculus
- Lysosomal alpha-glucosidase / Mus musculus
- Lysosome-associated membrane glycoprotein 2 / Mus musculus
- Metabotropic glutamate receptor 3 / Mus musculus
- Myelin-associated glycoprotein / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Prosaposin / Mus musculus
- Reticulocalbin-1 / Mus musculus
- Signal-regulatory protein alpha / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Wolframin / Mus musculus
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
Rhodopsin / Todarodes pacificus
- Undefined site
-
Tsl-1 antigens / Trichinella spiralis
- Undefined site
-
Uncharacterized protein from Whole Organism / Trichinella spiralis
- Undefined site
-
Hemocyanin / Megathura crenulata
- Undefined site
- Phospholipase a2 / Apis mellifera
-
Uncharacterized protein from Undefined tissue / Drosophila melanogaster
- Undefined site
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- LVLLPLVSSQCVNLTTR (17aa)
- LPLVSSQCVNLTTRTQLPPAYTNSFTR (27aa)
- FLVLLPLVSSQCVNLTTRTQLPPAYTNSFTR (31aa)
- FVFLVLLPLVSSQCVNL (17aa)
- LLPLVSSQCVNLTTR (15aa)
- QCVNLTTR (8aa)
- MFVFLVLLPLVSSQCVNL (18aa)
- FWIPHNVTWADIK (13aa)
- IWIPVNITWADIEDRDGR (18aa)
- HENNTKDNSIQHEFSLTR (18aa)
- VVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK (33aa)
- VAGTAVSISCNVSDYEGPAQQDFEWFMYRPEAPATSLGIVSTK (43aa)
- FLPFFSNVTWFHAIHVSGTNGTK (23aa)
- LPFFSNVTWFHAIHVSGTNGTKR (23aa)
- FFSNVTWFHAIHVSGTNGTKR (21aa)
- TDDEVVQREEEAIQIDGINASQIR (24aa)
- APLVNVTLYYEALCGGCR (18aa)
- NAPLVNVTLYYEALCGGCR (19aa)
- HAIHVSGTNGTKRF (14aa)
- HVSGTNGTKR (10aa)
- HSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEK (49aa)
- AIHVSGTNGTKR (12aa)
- HAIHVSGTNGTKR (13aa)
- DNATQEEILHYLEK (14aa)
- TVVTEAGNLLKDNATQEEILHYLEK (25aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- IRNVSDTTKR (10aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- NCTLLLSTLSPELGGK (16aa)
- GHTITINFTR (10aa)
- QLQALQQNGSSVLSE (15aa)
- DAMVGNYTCEVTELSR (16aa)
- VTTYCNETMTGWVHDVIGR (19aa)
- SISNSTAR (8aa)
- ANATLLLGPLR (11aa)
- LIVNNATNVVIK (12aa)
- LLIVNNATNVVIK (13aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATN (12aa)
- TQSLLIVNNATNVVIKVCEF (20aa)
- VNNATNVVIK (10aa)
- LGIYADMGNFTCMGYPGTTLDK (22aa)
- NGSGAVFPVAGADVQTLR (18aa)
- LENLSSTESGYTATLTR (17aa)
- QGAPLIATSVSSWQIPQNTSLPGAPSFIFSFHNAPHK (37aa)
- DPFLGVYYHKNNK (13aa)
- CNSVLTYNLTPVVQK (15aa)
- SEFRVYSSANNCTFE (15aa)
- QTPEYQNR (8aa)
- IIHAIGGDDFIGMINR (16aa)
- EDVYRNHSIFIADINQER (18aa)
- NHSIFLADINQER (13aa)
- NFTMNEK (7aa)
- NPCTSEQNCTSPFSYK (16aa)
- GINESYK (7aa)
- TNSSFIQGFVDHVKEDCDR (19aa)
- SIVYSCEWPIYMWPFQKPNYTEIR (24aa)
- VNGTWLQAGVVSWGEGCAQPNRPGIYTR (28aa)
- VNGTWLQAGVVSWGEGCAQPNRPGIYTR (28aa)
- QGFSALEPLVDLPIGINITR (20aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAA (50aa)
- LVRDLPQGFSALEPLVDLPIGINITRFQTLLALHR (35aa)
- EPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPR (50aa)
- PQGFSALEPLVDLPIGINITR (21aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSG (43aa)
- DLPQGFSALEPLVDLPIGINI (21aa)
- HTPINLVRDLPQGFSALEPLVDLPIGINITRFQTL (35aa)
- PLVDLPIGINITR (13aa)
- INITR (5aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYY (52aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTA (46aa)
- KDNTTVTR (8aa)
- YQYVDCGRNTT (11aa)
- IININPNK (8aa)
- YYHGELSYLNVTR (13aa)
- GSISYINVTR (10aa)
- GSLSYLNVTRK (11aa)
- VTQQSPTSMNQVNLTCR (17aa)
- KYNENGTITDAVD (13aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- LLKYNENGTITDAVDCALDPLSETK (25aa)
- IIAPAYFIIGGNQSGEGCVITR (22aa)
- ALIYQFSPIYTGNISSFQQ (19aa)
- FPNITNLCPFGEVFNATRFAS (21aa)
- VQPTESIVRFPN (12aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- PNITNL (6aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- IIDNNKTEK (9aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- VQPFNVTQGK (10aa)
- GIKPNQTSK (9aa)
- YHNQTIR (7aa)
- DECWCPANSTGK (12aa)
- NLEKNSTK (8aa)
- INFTAPFNPNK (11aa)
- KLVLYLEHNLEKNSTKEEILAALEK (25aa)
- NSTKEEILAALEK (13aa)
- LVLYLEHNLEKNSTKEEILAALEK (24aa)
- VFGSQNITTVK (11aa)
- NVTHSGR (7aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLY (35aa)
- NCTSFR (6aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- VLFHNLTQPR (10aa)
- HVNNSYE (7aa)
- VPGNQTSTTLK (11aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- AIPTNFTISVTTEILPVSMTK (21aa)
- IAIPTNFTISVTTEILPVSMTK (22aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGI (79aa)
- NFTISVTTEILPVSMTK (17aa)
- IPTNFTISVTTEILPVSMTK (20aa)
- CLYGEAYPSCSSGNTSTAEEELCR (24aa)
- FNFSQILPDPSKPSK (15aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- PIKDFGGFNFSQILPDPSK (19aa)
- VINETWAWK (9aa)
- NATLAEQAK (9aa)
- AEPPINASASDQGEK (15aa)
- AEPPLNASAGDQEEK (15aa)
- INYSIPTGQWVGVQIPR (17aa)
- NCTDIDECR (9aa)
- NCTDIDECR (9aa)
- NCTDIDECR (9aa)
- AQEKNFTTAPAICHDGK (17aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHW (11aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- GVFVSNGTHWFVTQR (15aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- SGINASVVNIQK (12aa)
- LGDISGINASVVNIQK (16aa)
- AKNLNESLIDLQELGK (16aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLK (54aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMV (39aa)
- NLNESL (6aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVT (40aa)
- EIDRLNEVAKNLNESLIDLQEL (22aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCC (45aa)
- VAKNLNE (7aa)
- LNEVAKNLNES (11aa)
- DRLNEVAKNLNESLIDLQELGK (22aa)
- NLNESLIDLQELGKY (15aa)
- VAKNLNESLIDLQE (14aa)
- NLNESLIDLQ (10aa)
- NLNESLID (8aa)
- FYFGGSPISAQYANFTGCISNAYFTR (26aa)
- TIETHSNK (8aa)
- NLQVYNATSNSLTVK (15aa)
- VETGENCTSPAPK (13aa)
- GVTHLNISGLK (11aa)
Mass spectrometry observed peptide
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Systematic Review of the Concentrations of Oligosaccharides in Human Milk (2017 - Stephan Thurl, Manfred Munzert, Günther Boehm, Catherine Matthews, Bernd Stahl) / Status : Unreviewed
- Human Milk Oligosaccharides (HMOS): Structure, Function, and Enzyme-Catalyzed Synthesis (2015 - Xi Chen) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
- Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation (2001 - Chaturvedi, Warren, Altaye, Morrow, Ruiz-Palacios, Pickering, Newburg) / Status : Reviewed
- Comparison of oligosaccharides in milk specimens from humans and twelve other species. (2001 - Warren CD, Chaturvedi P, Newburg AR, Oftedal OT, Tilden CD, Newburg DS) / Status : Reviewed
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Systematic Review of the Concentrations of Oligosaccharides in Human Milk (2017 - Stephan Thurl, Manfred Munzert, Günther Boehm, Catherine Matthews, Bernd Stahl) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
- Human Milk Oligosaccharides (HMOS): Structure, Function, and Enzyme-Catalyzed Synthesis (2015 - Xi Chen) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- Free / Lactose (avg mass : 1219.1179)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- N-Linked / High-Mannose (avg mass : 1219.1179)
- Pituitary Gland (UBERON_0000007)
-
Thyrotropin-aplha and beta chains / Bos taurus
- Undefined site
-
- N-Linked / High-Mannose (avg mass : 1219.1179)
-
Uncharacterized protein from Whole Organism / Trichinella spiralis
- Undefined site
-
- N-Linked / High-Mannose (avg mass : 1219.1179)
- Liver (UBERON_0002107) AH130 (CVCL_4367)
- Carcinoma, Hepatocellular (DOID:684)
-
Alkaline phosphatase, tissue non-specific isozyme / Rattus norvegicus
- Undefined site
-
- N-Linked / High-Mannose (avg mass : 1219.1179)
- Venom (UBERON_0007113)
- Phospholipase a2 / Apis mellifera
-
- N-Linked / High-Mannose (avg mass : 1219.1179)
-
Uncharacterized protein from Undefined tissue / Drosophila melanogaster
- Undefined site
-
- N-Linked / High-Mannose (avg mass : 1219.1179)
- Placenta (UBERON_0001987)
- Phosphorylcholine-containing N-glycans of Trichinella spiralis: identification of multiantennary lacdiNAc structures. (2000 - Morelle W, Haslam S, Olivier V, Appleton J, Morris H, Dell A) / Status : Reviewed
- High-mannose-type oligosaccharides from human placental arylsulfatase A are core fucosylated as confirmed by MALDI MS. (2000 - Hoja-Lukowicz D, Cioczyk D, Bergquist J, Lityska A, Laidler P) / Status : Reviewed
-
Arylsulfatase a / Homo sapiens
- Undefined site
-
Tsl-1 antigens / Trichinella spiralis
- Undefined site
-
- N-Linked / Hybrid (avg mass : 1219.1179)
- Kidney (UBERON_0002113) HEK293T (CVCL_0063)
- Adipocyte plasma membrane-associated protein / Homo sapiens
-
- N-Linked / Pauci-Mannose (avg mass : 1219.1179)
- Hemolymph (UBERON_0001011)
-
Hemocyanin / Megathura crenulata
- Undefined site
-
- N-Linked / Pauci-Mannose (avg mass : 1219.1179)
-
Rhodopsin / Todarodes pacificus
- Undefined site
-
- O-Linked / Undefined core (avg mass : 1219.1179)
-
Mucin / Capra hircus
- Undefined site
-
- Hex:4 HexNAc:2 dHex:1 / N-Linked (avg mass : 1219.1179)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- BTI-Tn-5B1-4 (CVCL_C190)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / High-Mannose / Man(?1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-3)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-6)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-?)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / High-Mannose / Man(a1-?)Man(a1-?)[Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Hybrid / Structure 834
- N-Linked / Pauci-Mannose / Gal(b1-6)Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Gal(b1-4)Fuc(a1-6)]GlcNAc
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Acid ceramidase / Homo sapiens
- Alpha-fetoprotein / Homo sapiens
- Alpha-galactosidase A / Homo sapiens
- Alpha-n-acetylgalactosaminidase / Homo sapiens
- Apolipoprotein d / Homo sapiens
- C-type mannose receptor 2 / Homo sapiens
- Cap-gly domain-containinglinker protein 1 / Homo sapiens
- Cathepsin D / Homo sapiens
- Cation-independent mannose-6-phosphate receptor / Homo sapiens
- Ceramide synthase 2 / Homo sapiens
- Ceramide synthase 6 / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Dipeptidyl peptidase 1 / Homo sapiens
- Endoplasmin / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrillin-2 / Homo sapiens
- Fibrillin-3 / Homo sapiens
- Gamma-glutamyl hydrolase / Homo sapiens
- Gamma-interferon-inducible lysosomal thiol reductase / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens
- Low-density lipoprotein receptor / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Multimerin-1 / Homo sapiens
- N-acetylglucosamine-6-sulfatase / Homo sapiens
- Neurocan core protein / Homo sapiens
- Palmitoyl-protein thioesterase 1 / Homo sapiens
- Prenylcysteine oxidase 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Serpin h1 / Homo sapiens
- Sortilin-related receptor / Homo sapiens
- Sulfhydryl oxidase 1 / Homo sapiens
- Tenascin / Homo sapiens
- Thyroglobulin / Homo sapiens
- Transmembrane protein 106B / Homo sapiens
- Transmembrane protein 245 / Homo sapiens
- Tryptase alpha/beta-1 / Homo sapiens
- Tryptase beta-2 / Homo sapiens
- Tyrosine-protein phosphatase non-receptor type substrate 1 / Homo sapiens
- Cathepsin D / Mus musculus
- G-protein coupled receptor 56 / Mus musculus
- Hypoxia up-regulated protein 1 / Mus musculus
- Immunoglobulin superfamily member 8 / Mus musculus
- Isoform 3 of Inositol 1,4,5-trisphosphate receptor type 1 / Mus musculus
- Leukocyte surface antigen CD47 / Mus musculus
- Lysosomal acid phosphatase / Mus musculus
- Lysosomal alpha-glucosidase / Mus musculus
- Lysosome-associated membrane glycoprotein 2 / Mus musculus
- Metabotropic glutamate receptor 3 / Mus musculus
- Myelin-associated glycoprotein / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Prosaposin / Mus musculus
- Reticulocalbin-1 / Mus musculus
- Signal-regulatory protein alpha / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Wolframin / Mus musculus
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LVLLPLVSSQCVNLTTR (17aa)
- LPLVSSQCVNLTTRTQLPPAYTNSFTR (27aa)
- FLVLLPLVSSQCVNLTTRTQLPPAYTNSFTR (31aa)
- FVFLVLLPLVSSQCVNL (17aa)
- LLPLVSSQCVNLTTR (15aa)
- QCVNLTTR (8aa)
- MFVFLVLLPLVSSQCVNL (18aa)
- FWIPHNVTWADIK (13aa)
- IWIPVNITWADIEDRDGR (18aa)
- HENNTKDNSIQHEFSLTR (18aa)
- VVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK (33aa)
- VAGTAVSISCNVSDYEGPAQQDFEWFMYRPEAPATSLGIVSTK (43aa)
- FLPFFSNVTWFHAIHVSGTNGTK (23aa)
- LPFFSNVTWFHAIHVSGTNGTKR (23aa)
- FFSNVTWFHAIHVSGTNGTKR (21aa)
- TDDEVVQREEEAIQIDGINASQIR (24aa)
- APLVNVTLYYEALCGGCR (18aa)
- NAPLVNVTLYYEALCGGCR (19aa)
- HAIHVSGTNGTKRF (14aa)
- HVSGTNGTKR (10aa)
- HSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEK (49aa)
- AIHVSGTNGTKR (12aa)
- HAIHVSGTNGTKR (13aa)
- DNATQEEILHYLEK (14aa)
- TVVTEAGNLLKDNATQEEILHYLEK (25aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- IRNVSDTTKR (10aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- NCTLLLSTLSPELGGK (16aa)
- GHTITINFTR (10aa)
- QLQALQQNGSSVLSE (15aa)
- DAMVGNYTCEVTELSR (16aa)
- VTTYCNETMTGWVHDVIGR (19aa)
- SISNSTAR (8aa)
- ANATLLLGPLR (11aa)
- LIVNNATNVVIK (12aa)
- LLIVNNATNVVIK (13aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATN (12aa)
- TQSLLIVNNATNVVIKVCEF (20aa)
- VNNATNVVIK (10aa)
- LGIYADMGNFTCMGYPGTTLDK (22aa)
- NGSGAVFPVAGADVQTLR (18aa)
- LENLSSTESGYTATLTR (17aa)
- QGAPLIATSVSSWQIPQNTSLPGAPSFIFSFHNAPHK (37aa)
- DPFLGVYYHKNNK (13aa)
- CNSVLTYNLTPVVQK (15aa)
- SEFRVYSSANNCTFE (15aa)
- QTPEYQNR (8aa)
- IIHAIGGDDFIGMINR (16aa)
- EDVYRNHSIFIADINQER (18aa)
- NHSIFLADINQER (13aa)
- NFTMNEK (7aa)
- NPCTSEQNCTSPFSYK (16aa)
- GINESYK (7aa)
- TNSSFIQGFVDHVKEDCDR (19aa)
- SIVYSCEWPIYMWPFQKPNYTEIR (24aa)
- VNGTWLQAGVVSWGEGCAQPNRPGIYTR (28aa)
- VNGTWLQAGVVSWGEGCAQPNRPGIYTR (28aa)
- QGFSALEPLVDLPIGINITR (20aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAA (50aa)
- LVRDLPQGFSALEPLVDLPIGINITRFQTLLALHR (35aa)
- EPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPR (50aa)
- PQGFSALEPLVDLPIGINITR (21aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSG (43aa)
- DLPQGFSALEPLVDLPIGINI (21aa)
- HTPINLVRDLPQGFSALEPLVDLPIGINITRFQTL (35aa)
- PLVDLPIGINITR (13aa)
- INITR (5aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYY (52aa)
- DLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTA (46aa)
- KDNTTVTR (8aa)
- YQYVDCGRNTT (11aa)
- IININPNK (8aa)
- YYHGELSYLNVTR (13aa)
- GSISYINVTR (10aa)
- GSLSYLNVTRK (11aa)
- VTQQSPTSMNQVNLTCR (17aa)
- KYNENGTITDAVD (13aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- LLKYNENGTITDAVDCALDPLSETK (25aa)
- IIAPAYFIIGGNQSGEGCVITR (22aa)
- ALIYQFSPIYTGNISSFQQ (19aa)
- FPNITNLCPFGEVFNATRFAS (21aa)
- VQPTESIVRFPN (12aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- PNITNL (6aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- IIDNNKTEK (9aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- VQPFNVTQGK (10aa)
- GIKPNQTSK (9aa)
- YHNQTIR (7aa)
- DECWCPANSTGK (12aa)
- NLEKNSTK (8aa)
- INFTAPFNPNK (11aa)
- KLVLYLEHNLEKNSTKEEILAALEK (25aa)
- NSTKEEILAALEK (13aa)
- LVLYLEHNLEKNSTKEEILAALEK (24aa)
- VFGSQNITTVK (11aa)
- NVTHSGR (7aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLY (35aa)
- NCTSFR (6aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- VLFHNLTQPR (10aa)
- HVNNSYE (7aa)
- VPGNQTSTTLK (11aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- AIPTNFTISVTTEILPVSMTK (21aa)
- IAIPTNFTISVTTEILPVSMTK (22aa)
- IIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGI (79aa)
- NFTISVTTEILPVSMTK (17aa)
- IPTNFTISVTTEILPVSMTK (20aa)
- CLYGEAYPSCSSGNTSTAEEELCR (24aa)
- FNFSQILPDPSKPSK (15aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- PIKDFGGFNFSQILPDPSK (19aa)
- VINETWAWK (9aa)
- NATLAEQAK (9aa)
- AEPPINASASDQGEK (15aa)
- AEPPLNASAGDQEEK (15aa)
- INYSIPTGQWVGVQIPR (17aa)
- NCTDIDECR (9aa)
- NCTDIDECR (9aa)
- NCTDIDECR (9aa)
- AQEKNFTTAPAICHDGK (17aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHW (11aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- GVFVSNGTHWFVTQR (15aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- SGINASVVNIQK (12aa)
- LGDISGINASVVNIQK (16aa)
- AKNLNESLIDLQELGK (16aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLK (54aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMV (39aa)
- NLNESL (6aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVT (40aa)
- EIDRLNEVAKNLNESLIDLQEL (22aa)
- NLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCC (45aa)
- VAKNLNE (7aa)
- LNEVAKNLNES (11aa)
- DRLNEVAKNLNESLIDLQELGK (22aa)
- NLNESLIDLQELGKY (15aa)
- VAKNLNESLIDLQE (14aa)
- NLNESLIDLQ (10aa)
- NLNESLID (8aa)
- FYFGGSPISAQYANFTGCISNAYFTR (26aa)
- TIETHSNK (8aa)
- NLQVYNATSNSLTVK (15aa)
- VETGENCTSPAPK (13aa)
- GVTHLNISGLK (11aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Disease
Reported glycosite
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
